NUVL
Nuvalent, Inc.
NASDAQ · USHealthcareBiotechnology
$123.96+0.00%
Price as of Jul 14, 2026
NUVL ownership
Nuvalent, Inc. ownership & insider activity
Latest available institutional positioning and SEC Form 4 insider transactions, coalesced at the company entity level when listings share coverage.
Insider Activity
Sentiment
0/100
Buys (3m)
0
Sells (3m)
31
Net (3m)
-$20.5M
Insider trades by month Buys Sells
Feb
Mar
Apr
May
Jun
Jul
Context3-month price +18.3%Institutions accumulating (13F)
| Date | Insider | Type | Shares | Price |
|---|---|---|---|---|
| Jul 15, 2026 | Lane Benjaminofficer: See Remarks | Grant | 7,120 | — |
| Jul 15, 2026 | Turner Christopher Durantofficer: Chief Medical Officer | Grant | 14,350 | — |
| Jul 15, 2026 | Noci Darleneofficer: Chief Development Officer | Grant | 14,350 | — |
| Jul 15, 2026 | Miller Deborah Annofficer: Chief Legal Officer | Grant | 14,350 | — |
| Jul 15, 2026 | Balcom Alexandraofficer: Chief Financial Officer | Grant | 14,350 | — |
| Jul 15, 2026 | Porter James Richarddirector, officer: President and CEO | Grant | 40,025 | — |
| Jul 15, 2026 | Pelish Henry E.officer: Chief Scientific Officer | Grant | 14,350 | — |
| Jul 10, 2026 | Pelish Henry E.officer: Chief Scientific Officer | Sell | 2,111 | $123.81 |
| Jul 8, 2026 | Porter James Richarddirector, officer: President and CEO | Sell | 30,000 | $123.72 |
| Jul 8, 2026 | Porter James Richarddirector, officer: President and CEO | Option | 30,000 | $18.93 |
| Jul 6, 2026 | Balcom Alexandraofficer: Chief Financial Officer | Option | 5,384 | $6.89 |
| Jul 6, 2026 | Noci Darleneofficer: Chief Development Officer | Option | 13,854 | $72.35 |
| Jul 6, 2026 | Noci Darleneofficer: Chief Development Officer | Option | 9,146 | $18.93 |
| Jul 6, 2026 | Balcom Alexandraofficer: Chief Financial Officer | Option | 6,046 | $18.93 |
| Jul 6, 2026 | Balcom Alexandraofficer: Chief Financial Officer | Sell | 11,430 | $123.58 |
| Jul 6, 2026 | Noci Darleneofficer: Chief Development Officer | Sell | 23,000 | $123.59 |
| Jul 1, 2026 | Noci Darleneofficer: Chief Development Officer | Option | 5,500 | $27.85 |
| Jul 1, 2026 | Noci Darleneofficer: Chief Development Officer | Sell | 5,500 | $123.51 |
| Jun 18, 2026 | Flynn James Edirector, 10 percent owner, other: Director by Deputization | Grant | 3,444 | — |
| Jun 18, 2026 | Wheeler Camerondirector | Grant | 3,444 | — |
| Jun 18, 2026 | Srivastava Sapnadirector | Grant | 3,444 | — |
| Jun 18, 2026 | Oliger Christy J.director | Grant | 3,444 | — |
| Jun 18, 2026 | Meyers Michael L.director | Grant | 3,444 | — |
| Jun 18, 2026 | Squarer Rondirector | Grant | 3,444 | — |
| Jun 18, 2026 | Bogle Grant C.director | Grant | 3,444 | — |
| Jun 18, 2026 | Protopapas Annadirector | Grant | 3,444 | — |
| Jun 11, 2026 | Noci Darleneofficer: Chief Development Officer | Option | 9,315 | $18.93 |
| Jun 11, 2026 | Noci Darleneofficer: Chief Development Officer | Option | 685 | $6.89 |
| Jun 11, 2026 | Noci Darleneofficer: Chief Development Officer | Sell | 20,000 | $122.81 |
| Jun 11, 2026 | Noci Darleneofficer: Chief Development Officer | Option | 10,000 | $1.08 |
Source: NUVL SEC Form 4 filings, latest Jul 15, 2026. For informational purposes only — not investment advice.
Institutional activity (13F)
How institutions changed their NUVL positions over the last 6 months (SEC Form 13F).
Increased
212
New positions
114
Reduced
123
Sold out
48
Largest moves
| Institution | Action | Shares | Filed |
|---|---|---|---|
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | Unchanged | 17.2M | May 15, 2026 |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | Reduced | 17.2M | Feb 17, 2026 |
| FMR LLC | Increased | 10.9M | Feb 17, 2026 |
| FMR LLC | Reduced | 9.3M | May 15, 2026 |
| PARADIGM BIOCAPITAL ADVISORS LP | Increased | 5.3M | May 15, 2026 |
| PARADIGM BIOCAPITAL ADVISORS LP | Unchanged | 5.3M | Feb 17, 2026 |
| VANGUARD GROUP INC | Increased | 5.2M | Jan 29, 2026 |
| BLACKROCK, INC. | Increased | 4.8M | May 13, 2026 |
| BLACKROCK, INC. | Increased | 4.8M | Feb 12, 2026 |
| JPMORGAN CHASE & CO | Increased | 3.1M | May 13, 2026 |
| RA CAPITAL MANAGEMENT, L.P. | Increased | 2.5M | May 15, 2026 |
| VANGUARD PORTFOLIO MANAGEMENT LLC | New Position | 2.5M | May 8, 2026 |
| WELLINGTON MANAGEMENT GROUP LLP | Increased | 2.5M | May 15, 2026 |
| WELLINGTON MANAGEMENT GROUP LLP | Increased | 2.5M | Feb 17, 2026 |
| VANGUARD CAPITAL MANAGEMENT LLC | New Position | 2.4M | May 15, 2026 |
Source: SEC Form 13F filings. For informational purposes only — not investment advice.